Systematic review / meta-analysis / 2014
Saffron demonstrated antidepressant effects in clinical trials for mild-to-moderate depression.
This systematic review synthesized findings from six randomized, double-blind trials comparing saffron to placebo or antidepressant drugs. Saffron produced substantial clinical benefits compared to placebo and demonstrated similar efficacy when benchmarked against pharmaceutical antidepressants. A narrative review suggested serotonergic, antioxidant, anti-inflammatory, and neuroprotective pathways may underlie these antidepressant properties.
- Study type
- Systematic review of clinical trials
- Who was studied
- Individuals with mild-to-moderate depression across 6 clinical trials
- What was measured
- Antidepressant efficacy and treatment effects
THE PAPER
Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action.
Lopresti AL, Drummond PD. Hum Psychopharmacol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.